Brain, Vol. 115, No. 3, 735-748, 1992
© 1992 Guarantors of Brain
research-article |
WHITE MATTER LESIONS ON MAGNETIC RESONANCE IMAGING IN CLINICALLY DIAGNOSED ALZHEIMER'S DISEASE: EVIDENCE FOR HETEROGENEITY
1Department of Neurology Diagnostic Radiology, Free University Hospital Amsterdam 2Department of Diagnostic Radiology, Free University Hospital Amsterdam 3Theory of Medicine, Epidemiology and Biostatistics, Free University Amsterdam, The Netherlands
Correspondence to:
Correspondence to: Ph. Scheltens, MD, Department of Neurology, Free University Hospital, PO Box 7057. 1007 MB Amsterdam, The Netherlands.
In a prospective magnetic resonance imaging (MRI) study we evaluted the prevalence and severity of white matter changes in 29 patients with Alzheimer's Disease (AD) and 24 age-matched healthy elderly, all without cerebrovascular risk factors.
The AD patients were divided into two groups according to age at onset of symptoms, one with presenile onset AD (n = 13) and one with senile onset AD (n = 16), who were matched for dementia severity. Signal hyperintensities were rated using a semiquantative scoring method, separately in the periventricular region (PVH) and in the lobar white matter (WMH), as well as in the basal ganglia (BGH) and in the infratentorial region (ITFH). Cortical atrophy as a parameter of grey matter involvement was rated on a 0 (absent) to 3 (severe) scale.
We found PVH, WMH and BGH scores to be significantly higher in senile onset AD patients than in age-matched controls. By means of multiple linear logistic regression we found that PVH, WMH and BGH scores were significantly dependent on the diagnosis of senile onset AD, while the PVH score also showed a significant age dependency. Cortical atrophy did not differ significantly between presenile onset AD and senile onset AD patients.
These results indicate that presenile onset AD and senile onset AD patients differ with respect to white matter involvement, but not with respect to grey matter involvement on MRI. Since cerebrovascular risk factors were excluded these findings may indicate that senile onset AD patients, display more small vessel involvement (arteriolosclerosis) than presenile onset AD patients, suggesting additional (microvascular) factors for the dementia syndrome in senile onset AD. Our data lend support to the growing body of evidence that AD is heterogeneous, consisting of at least two types. Based on our findings two forms can be distinguished: (i) a ‘pure’ form of the disease, usually with early disease onset, and no more white matter changes than normal for age; (ii) a ‘mixed’ form, usually with disease onset later in life, and showing more white matter changes on MRI than normal for age.
Received October 24, 1991. Accepted February 2, 1992.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. T. Baune, W. P. Schmidt, A. Roesler, and K. Berger Functional Consequences of Subcortical White Matter Lesions and MRI-Defined Brain Infarct in an Elderly General Population J Geriatr Psychiatry Neurol, December 1, 2009; 22(4): 266 - 273. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Y. Lee, E. Fletcher, O. Martinez, M. Ortega, N. Zozulya, J. Kim, J. Tran, M. Buonocore, O. Carmichael, and C. DeCarli Regional pattern of white matter microstructural changes in normal aging, MCI, and AD Neurology, November 24, 2009; 73(21): 1722 - 1728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. T. Baune, A. Roesler, S. Knecht, and K. Berger Single and Combined Effects of Cerebral White Matter Lesions and Lacunar Infarctions on Cognitive Function in an Elderly Population J Gerontol A Biol Sci Med Sci, January 27, 2009; (2009) gln004v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Brickman, L. S. Honig, N. Scarmeas, O. Tatarina, L. Sanders, M. S. Albert, J. Brandt, D. Blacker, and Y. Stern Measuring Cerebral Atrophy and White Matter Hyperintensity Burden to Predict the Rate of Cognitive Decline in Alzheimer Disease Arch Neurol, September 1, 2008; 65(9): 1202 - 1208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.J. Bastos-Leite, J.P.A. Kuijer, S.A.R.B. Rombouts, E. Sanz-Arigita, E.C. van Straaten, A.A. Gouw, W.M. van der Flier, P. Scheltens, and F. Barkhof Cerebral Blood Flow by Using Pulsed Arterial Spin-Labeling in Elderly Subjects with White Matter Hyperintensities AJNR Am. J. Neuroradiol., August 1, 2008; 29(7): 1296 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Libon, C. C. Price, T. Giovannetti, R. Swenson, B. M. Bettcher, K. M. Heilman, and A. Pennisi Linking MRI Hyperintensities With Patterns of Neuropsychological Impairment: Evidence for a Threshold Effect Stroke, March 1, 2008; 39(3): 806 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Bastos-Leite, W. M. van der Flier, E. C.W. van Straaten, S. S. Staekenborg, P. Scheltens, and F. Barkhof The Contribution of Medial Temporal Lobe Atrophy and Vascular Pathology to Cognitive Impairment in Vascular Dementia Stroke, December 1, 2007; 38(12): 3182 - 3185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L BRONGE and L-O WAHLUND White matter changes in dementia: does radiology matter? Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S115 - S120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D S KNOPMAN Cerebrovascular disease and dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S121 - S127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S MILLS, J CAIN, N PURANDARE, and A JACKSON Biomarkers of cerebrovascular disease in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S128 - S145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Y. Lee, I. H. Choo, K. W. Kim, J. H. Jhoo, J. C. Youn, U. Y. Lee, and J. I. Woo White Matter Changes Associated With Psychotic Symptoms in Alzheimer's Disease Patients J Neuropsychiatry Clin Neurosci, May 1, 2006; 18(2): 191 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Burns, J. A. Church, D. K. Johnson, C. Xiong, D. Marcus, A. F. Fotenos, A. Z. Snyder, J. C. Morris, and R. L. Buckner White Matter Lesions Are Prevalent but Differentially Related With Cognition in Aging and Early Alzheimer Disease Arch Neurol, December 1, 2005; 62(12): 1870 - 1876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bocti, R. H. Swartz, F.-Q. Gao, D. J. Sahlas, P. Behl, and S. E. Black A New Visual Rating Scale to Assess Strategic White Matter Hyperintensities Within Cholinergic Pathways in Dementia Stroke, October 1, 2005; 36(10): 2126 - 2131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F-E de Leeuw, F Barkhof, and P Scheltens Alzheimer's disease--one clinical syndrome, two radiological expressions: a study on blood pressure J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1270 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Artero, H Tiemeier, N D Prins, R Sabatier, M M B Breteler, and K Ritchie Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1304 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A A Capizzano, L Acion, T Bekinschtein, M Furman, H Gomila, A Martinez, R Mizrahi, and S E Starkstein White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(6): 822 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Tian, J Shi, K Bailey, C L Lendon, S M Pickering-Brown, and D M A Mann Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, May 1, 2004; 75(5): 696 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tuominen, Q. Miao, T. Kurki, S. Tuisku, M. Poyhonen, H. Kalimo, M. Viitanen, H. T. Sipila, J. Bergman, and J. O. Rinne Positron Emission Tomography Examination of Cerebral Blood Flow and Glucose Metabolism in Young CADASIL Patients Stroke, May 1, 2004; 35(5): 1063 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-E. de Leeuw, F. Richard, J. C. de Groot, C. M. van Duijn, A. Hofman, J. van Gijn, and M. M.B. Breteler Interaction Between Hypertension, apoE, and Cerebral White Matter Lesions Stroke, May 1, 2004; 35(5): 1057 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. O'Riordan, P. McMonagle, J. C. Janssen, N. C. Fox, M. Farrell, J. Collinge, M. N. Rossor, and M. Hutchinson Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities Neurology, October 8, 2002; 59(7): 1108 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Wu, D. Mungas, C. I. Petkov, J. L. Eberling, P. A. Zrelak, M. H. Buonocore, J. A. Brunberg, M. N. Haan, and W. J. Jagust Brain structure and cognition in a community sample of elderly Latinos Neurology, August 13, 2002; 59(3): 383 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hogervorst, H. M. Ribeiro, A. Molyneux, M. Budge, and A. D. Smith Plasma Homocysteine Levels, Cerebrovascular Risk Factors, and Cerebral White Matter Changes (Leukoaraiosis) in Patients With Alzheimer Disease Arch Neurol, May 1, 2002; 59(5): 787 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tuominen, V. Juvonen, K. Amberla, T. Jolma, J. O. Rinne, S. Tuisku, T. Kurki, R. Marttila, M. Poyhonen, M.-L. Savontaus, et al. Phenotype of a Homozygous CADASIL Patient in Comparison to 9 Age-Matched Heterozygous Patients With the Same R133C Notch3 Mutation Stroke, August 1, 2001; 32(8): 1767 - 1774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Campbell III and C. E. Coffey Neuropsychiatric Significance of Subcortical Hyperintensity J Neuropsychiatry Clin Neurosci, May 1, 2001; 13(2): 261 - 288. [Full Text] [PDF]
|
|
|
|
|
|
M. O'Sullivan, J.M. Jarosz, R.J. Martin, N. Deasy, J.F. Powell, and H.S. Markus MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL Neurology, March 13, 2001; 56(5): 628 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lobotesis, J.D. Fenwick, A. Phipps, A. Ryman, A. Swann, C. Ballard, I.G. McKeith, and J.T. O'Brien Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD Neurology, March 13, 2001; 56(5): 643 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F-E de Leeuw, J C de Groot, E Achten, M Oudkerk, L M P Ramos, R Heijboer, A Hofman, J Jolles, J van Gijn, and M M B Breteler Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study J. Neurol. Neurosurg. Psychiatry, January 1, 2001; 70(1): 9 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hirono, H. Kitagaki, H. Kazui, M. Hashimoto, and E. Mori Impact of White Matter Changes on Clinical Manifestation of Alzheimer's Disease : A Quantitative Study Stroke, September 1, 2000; 31(9): 2182 - 2188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hirono, M. Yasuda, S. Tanimukai, H. Kitagaki, and E. Mori Effect of the Apolipoprotein E {epsilon}4 Allele on White Matter Hyperintensities in Dementia Stroke, June 1, 2000; 31(6): 1263 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sjogren, L. Rosengren, L. Minthon, P. Davidsson, K. Blennow, and A. Wallin Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD Neurology, May 23, 2000; 54(10): 1960 - 1964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-E. de Leeuw, J. C. de Groot, M. Oudkerk, J. A. Kors, A. Hofman, J. van Gijn, and M. M. B. Breteler Atrial fibrillation and the risk of cerebral white matter lesions Neurology, May 9, 2000; 54(9): 1795 - 1801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Barber, P Scheltens, A Gholkar, C Ballard, I McKeith, P Ince, R Perry, and J O'Brien White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging J. Neurol. Neurosurg. Psychiatry, July 1, 1999; 67(1): 66 - 72. [Abstract] [Full Text]
|
|
|
|
|
|
G. T. Whitman, P. L. DiPatre, I. A. Lopez, F. Liu, N. E. Noori, H. V. Vinters, and R. W. Baloh Neuropathology in older people with disequilibrium of unknown cause Neurology, July 1, 1999; 53(2): 375 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Andreasen, C. Hesse, P. Davidsson, L. Minthon, A. Wallin, B. Winblad, H. Vanderstichele, E. Vanmechelen, and K. Blennow Cerebrospinal Fluid {beta}-Amyloid(1-42) in Alzheimer Disease: Differences Between Early- and Late-Onset Alzheimer Disease and Stability During the Course of Disease Arch Neurol, June 1, 1999; 56(6): 673 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Teipel, H. Hampel, P. Pietrini, G. E. Alexander, B. Horwitz, E. Daley, H.-J. Moller, M. B. Schapiro, and S. I. Rapoport Region-Specific Corpus Callosum Atrophy Correlates With the Regional Pattern of Cortical Glucose Metabolism in Alzheimer Disease Arch Neurol, April 1, 1999; 56(4): 467 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chabriat, R. Mrissa, C. Levy, K. Vahedi, H. Taillia, M. T. Iba-Zizen, A. Joutel, E. Tournier-Lasserve, and M.-G. Bousser Brain Stem MRI Signal Abnormalities in CADASIL Stroke, February 1, 1999; 30(2): 457 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R STEWART Cardiovascular factors in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, August 1, 1998; 65(2): 143 - 147. [Full Text]
|
|
|
|
|
|
J. V Bowler, D. G Munoz, H. Merskey, and V. Hachinski Factors affecting the age of onset and rate of progression of Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, August 1, 1998; 65(2): 184 - 190. [Abstract] [Full Text]
|
|
|
|
|
|
H. Hampel, S. J. Teipel, G. E. Alexander, B. Horwitz, D. Teichberg, M. B. Schapiro, and S. I. Rapoport Corpus Callosum Atrophy Is a Possible Indicator of Region- and Cell Type-Specific Neuronal Degeneration in Alzheimer Disease: A Magnetic Resonance Imaging Analysis Arch Neurol, February 1, 1998; 55(2): 193 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mantyla, T. Erkinjuntti, O. Salonen, H. J. Aronen, T. Peltonen, T. Pohjasvaara, and C.-G. Standertskjold-Nordenstam Variable Agreement Between Visual Rating Scales for White Matter Hyperintensities on MRI : Comparison of 13 Rating Scales in a Poststroke Cohort Stroke, August 1, 1997; 28(8): 1614 - 1623. [Abstract] [Full Text]
|
|
|
|
|
|
V. Jelic, P. Julin, M. Shigeta, A. Nordberg, L. Lannfelt, B. Winblad, and L.-O. Wahlund Apolipoprotein E epsilon 4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence J. Neurol. Neurosurg. Psychiatry, July 1, 1997; 63(1): 59 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S E Starkstein, L Sabe, S Vazquez, G Di Lorenzo, A Martinez, G Petracca, A Teson, E Chemerinski, and R Leiguarda Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, July 1, 1997; 63(1): 66 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. V. Bowler, M. Eliasziw, R. Steenhuis, D. G. Munoz, R. Fry, H. Merskey, and V. C. Hachinski Comparative Evolution of Alzheimer Disease, Vascular Dementia, and Mixed Dementia Arch Neurol, June 1, 1997; 54(6): 697 - 703. [Abstract] [PDF]
|
|
|
|
|
|
M. Bornebroek, J. Haan, M. A. van Buchem, J. B. K. Lanser, M. A. C. S. de Vries-vd Weerd, M. Zoeteweij, and R. A. C. Roos White Matter Lesions and Cognitive Deterioration in Presymptomatic Carriers of the Amyloid Precursor Protein Gene Codon 693 Mutation Arch Neurol, January 1, 1996; 53(1): 43 - 48. [Abstract] [PDF]
|
|
|
|
|
|
L. Pantoni and J. H. Garcia The Significance of Cerebral White Matter Abnormalities 100 Years After Binswanger's Report : A Review Stroke, July 1, 1995; 26(7): 1293 - 1301. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Xu, S. Chen, S. H. Ahmed, H. Chen, G. Ku, M. P. Goldberg, and C. Y. Hsu Amyloid-{beta} Peptides Are Cytotoxic to Oligodendrocytes J. Neurosci., January 1, 2001; 21(1): RC118 - RC118. [Abstract] [Full Text] [PDF]
|
|